Company / Share Buybacks
Arcus Biosciences, Inc. Share Buybacks History
FY2019-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$94.0K
FY2019
5-year range
-
FY2019-FY2019
Trend
-
vs FY2018
Sector context
#41 of 48
Health Care
What the data says
Arcus Biosciences, Inc.'s share buybacks of $94,000 is lower than 85% of companies in the Health Care sector (FY2019).
Based on SEC 10-K filings.
$94,000 in FY2019.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 48This company $94.0K Sector average $611.9M
▼
-100.0% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $94.0K | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026